IVD Earnings Roundup: Roche's Diabetes Division Takes A Dip; Quest Diagnostics; bioMérieux; Danaher
Executive Summary
Roche's diabetes business continues to struggle as third quarter results show sales in the division dipped by 3%, while Quest Diagnostics' bottom line took a hit from special charges. Meanwhile, bioMérieux said third-quarter revenues increased by 7%; Danaher is finalizing its acquisition of Cepheid.